Diabetes Devices Market (By Product Types: Monitoring Devices, Treatment Devices; By End User: Diagnostic Centers, Hospitals, Home Care, Ambulatory Surgery Centers; By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 190

The market for diabetes devices is expected to grow at a CAGR of around 6.0% from 2020 to 2027 and expected to reach the market value of around US$ 35,956.7 Mn by 2027.

Diabetes devices are used for the diagnosis of blood glucose levels in the body due to inadequate insulin levels. These devices help inefficient monitoring of blood glucose levels and associated treatment. Types of diabetes include type-1 diabetes, type-2 diabetes, and prediabetes. The market is experiencing the emergence of innovative devices that have automated and streamlined much of the work involved in diabetes management.

Market Dynamics

The rising prevalence of diabetes along with the increasing geriatric population across the globe is primarily driving the market value. Technological advancement in diabetes devices by manufacturers and rising investment in research and development activities is supporting the market value. The rising awareness about diabetes preventive care and increasing investment by people on health and safety products are additionally bolstering market growth. Moreover, ongoing technological advancements and the introduction of advanced insulin delivery devices are projected to create potential opportunities over the estimated period.

On the other side, low per capita expenditure on diabetes and lack of favorable reimbursement policies are projected to hinder the growth over the estimated timeframe from 2020 to 2027.

Hospital pharmacies registered maximum market share in terms of value in 2019

By distribution channels, hospital pharmacies are leading the market with major share. The availability of a variety of products associated with type 1, type 2 and prediabetes is supporting the segmental market value. The increasing number of diabetes device sales in these pharmacies further support the segment growth.

Hospitals accounted for the major share by end user in global diabetes devices market

By end-user, hospitals are leading the global market with major share. The rising healthcare expenditure in hospitals and improving infrastructure majorly in developing economies is driving the segment market value. Additionally, the home care segment is projected to exhibit the fastest growth over the forecast timeframe from 2020 to 2027.

The market research study on “Diabetes Devices Market– Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 – 2027”, offers a detailed insight into the global diabetes devices market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights into the global Diabetes Devices market, its product type, end user, distribution channels and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers global diabetes devices market size and volume, and segment markets by product type, end user, distribution channels, and geography along with the information on companies operating in the market. The diabetes devices market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments have been covered under the scope of the report.

North America dominated the global market with major share

In 2019, North America accounted for the major share in the diabetes devices market. The rising prevalence of chronic diseases including diabetes in the region is primarily driving the market value. The changing lifestyle, advanced healthcare products, the presence of leading manufacturers, and awareness about the healthcare products and services in the regional market is further supporting the market value. Apart from this, Asia Pacific region is projected to exhibit the fastest growth over the estimated period owing to the increasing disposable income, rising awareness about health and safety products, favorable government support. 

The players profiled in the report include Abbott Laboratories, Arkray, Inc., B Braun Melsungen AG, Bayer AG, Lifescan, Inc., Companion Medical, Dexcom Inc., F.Hoffmann-La-Ltd., Insulet Corporation, Lifescan, Inc., Medtronic plc, Novo Nordisk, Sanofi, Valeritas Holding Inc., and Ypsomed Holdings.

Market Segmentation

Market By Product Types

Monitoring Devices

  • Self-Monitoring Blood Glucose Device (SMBG)
  • Continuous Blood Glucose Monitoring (CGM)

Treatment Devices

  • Insulin Pens
  • Insulin Pumps
  • Insulin Jet Injectors
  • Insulin Syringes
  • Others

Market By End User

  • Diagnostic Centers
  • Hospitals
  • Home Care
  • Ambulatory Surgery Centers

Market By Distribution Channels

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

Market By Geography

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Spain
  • Rest of Europe

Asia-Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa


Frequently Asked Questions

Diabetes devices are used for the diagnosis of blood glucose levels in the body due to inadequate insulin levels.

The global diabetes devices market is expected to grow at a CAGR of 6.0% from 2020 to 2027.

The global diabetes devices market is expected to reach the market value of around US$ 35,956.7 Mn by 2027.

The rising prevalence of diabetes along with the increasing geriatric population across the globe is primarily driving the market value.

By end-user, hospitals are leading the global market with major share.

In 2019, North America accounted for the major share in the diabetes devices market.

Asia Pacific region is projected to exhibit the fastest growth over the estimated period owing to the increasing disposable income, rising awareness about health and safety products, favorable government support.

Cart Summary


60